Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00442013 · ClinicalTrials.gov registry record · Phase 4
Lansoprazole to Treat Children With Asthma
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 306
- Enrollment target
NCT00442013: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT00442013 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 306 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00442013, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 306 participants
- Enrollment target
Study Summary
Many individuals with asthma also experience gastroesophageal reflux disease (GERD), a condition in which excess stomach acid flows backwards into the esophagus. This study will evaluate the effectiveness of lansoprazole, a medication commonly used to treat GERD in improving asthma control and reducing symptoms in children with poorly controlled asthma.
Interventions
- DRUG Matching placebo
- DRUG Lansoprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2007-03 |
| Est. Completion | 2011-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00442013
The ClinicalTrials.gov registry entry for NCT00442013 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 306 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Matching placebo is the first listed.
NCT00442013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00442013 about?
NCT00442013 is a clinical study titled "Lansoprazole to Treat Children With Asthma". Many individuals with asthma also experience gastroesophageal reflux disease (GERD), a condition in which excess stomach acid flows backwards into the esophagus. This study will evaluate the effectiveness of lansoprazole, a medication commonly used to treat GERD in improving asthma control and reduc...
What is the current status of trial NCT00442013?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 306 participants. The study started on 2007-03. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00442013?
The interventions under investigation include: Matching placebo (DRUG), Lansoprazole (DRUG).
Who is sponsoring clinical trial NCT00442013?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.